0001019687-16-006603.txt : 20160608 0001019687-16-006603.hdr.sgml : 20160608 20160608082312 ACCESSION NUMBER: 0001019687-16-006603 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160608 DATE AS OF CHANGE: 20160608 EFFECTIVENESS DATE: 20160608 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CV Sciences, Inc. CENTRAL INDEX KEY: 0001510964 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 800944970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-264539 FILM NUMBER: 161702715 BUSINESS ADDRESS: STREET 1: 2688 SOUTH RAINBOW AVENUE, SUITE B CITY: LAS VEGAS STATE: NV ZIP: 89146 BUSINESS PHONE: 866-290-2157 MAIL ADDRESS: STREET 1: 2688 SOUTH RAINBOW AVENUE, SUITE B CITY: LAS VEGAS STATE: NV ZIP: 89146 FORMER COMPANY: FORMER CONFORMED NAME: CannaVEST Corp. DATE OF NAME CHANGE: 20130205 FORMER COMPANY: FORMER CONFORMED NAME: Foreclosure Solutions, Inc. DATE OF NAME CHANGE: 20110124 D 1 primary_doc.xml X0707 D LIVE 0001510964 CV Sciences, Inc. 2688 SOUTH RAINBOW BOULEVARD, SUITE B LAS VEGAS NV NEVADA 89146 866-290-2157 DELAWARE None CannaVEST Corp. Foreclosure Solutions, Inc. Corporation true Michael Mona, Jr. 2688 SOUTH RAINBOW BOULEVARD, SUITE B LAS VEGAS NV NEVADA 89146 Executive Officer Director Michael Mona, III 2688 SOUTH RAINBOW BOULEVARD, SUITE B LAS VEGAS NV NEVADA 89146 Executive Officer Director JOSEPH DOWLING 2688 SOUTH RAINBOW BOULEVARD, SUITE B LAS VEGAS NV NEVADA 89146 Executive Officer GARY SLIGAR 2688 SOUTH RAINBOW BOULEVARD, SUITE B LAS VEGAS NV NEVADA 89146 Director LARRY RASKIN 2688 SOUTH RAINBOW BOULEVARD, SUITE B LAS VEGAS NV NEVADA 89146 Director JAMES MCNULTY 2688 SOUTH RAINBOW BOULEVARD, SUITE B LAS VEGAS NV NEVADA 89146 Director Other Decline to Disclose 06b false 2016-05-25 false true true Secured Convertible Promissory Note; Common Stock into which such Note converts false 2000000 Meyers Associates, L.P. 34171 None None 45 BROADWAY, SECOND FLOOR NEW YORK NY NEW YORK 10006 IL ILLINOIS false 2000000 2000000 0 Total offering amount includes an "original issue discount" of 2.25% and other discounts (e.g., payment of Investor's legal fees, etc.) totaling approximately 2.68% of the total $2,055,000 in funds to be received by the Issuer. false 1 25000 0 0 false CV Sciences, Inc. /s/ Joseph Dowling Joseph Dowling Chief Financial Officer 2016-06-07